(Telegraph: Questor) If Aviva can still yield 7pc after a dividend cut, income seekers should buy
(Telegraph) Buy M&S treats via Ocado by all means, but leave its shares on the shelf
(Telegraph) Don’t trade Johnson Matthey in for a new model just yet
(Telegraph) It’s not Big Pharma but Clinigen has spotted some promising drug niches
(Telegraph) Lock away your Big Yellow shares – Covid will not blow its long-term strategy off course
(Times: Interview) Amundi boss Yves Perrier is not about to let the pandemic burst his bubble
(Telegraph) Bunzl delivered for customers during lockdown, now it will do the same for investors
(Times: Interview) Answering the questions posed by Covid will be good for business, says Arup chair
(Telegraph) Greencoat UK Wind is worth revisiting as political wind blows in the right direction
(Telegraph: Questor) When stock markets go mad, this spread-betting company benefits. Buy
(Telegraph: Questor) Frontier Developments has a rosy future yet the shares have been sliding. Buy
(Telegraph: Questor) NMC still has potential but there’s no room for such shoddy controls. Sell
(Telegraph: Questor) The NHS needs outside capital and this trust has made hay by providing it
Questor: Electrocomponents could get worse before it gets better – bank a 15pc gain and sell
(Telegraph: Questor) Moneysupermarket.com has matured and growth will be harder. Sell
(Times: Interview) Divide audit and consulting at Deloitte? Not on my watch, says CEO
(Telegraph: Questor) Smiths is doing the splits but it may not be enough to get shares moving
(Telegraph: Questor) Travis Perkins’ makeover is working and stamp duty reform would help too. Buy
(Telegraph: Interview) British Council chairman Stevie Spring: Smart power better than soft power
(Telegraph: Questor) There were plenty of hits this year but we must take stock of the misses too